These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
396 related items for PubMed ID: 1973780
1. Genetic variation in response to 6-mercaptopurine for childhood acute lymphoblastic leukaemia. Lennard L, Lilleyman JS, Van Loon J, Weinshilboum RM. Lancet; 1990 Jul 28; 336(8709):225-9. PubMed ID: 1973780 [Abstract] [Full Text] [Related]
2. Thiopurine methyltransferase deficiency in childhood lymphoblastic leukaemia: 6-mercaptopurine dosage strategies. Lennard L, Lewis IJ, Michelagnoli M, Lilleyman JS. Med Pediatr Oncol; 1997 Oct 28; 29(4):252-5. PubMed ID: 9251729 [Abstract] [Full Text] [Related]
3. Thiopurine methyltransferase genotype-phenotype discordance and thiopurine active metabolite formation in childhood acute lymphoblastic leukaemia. Lennard L, Cartwright CS, Wade R, Richards SM, Vora A. Br J Clin Pharmacol; 2013 Jul 28; 76(1):125-36. PubMed ID: 23252716 [Abstract] [Full Text] [Related]
4. Thiopurine pharmacogenetics in leukemia: correlation of erythrocyte thiopurine methyltransferase activity and 6-thioguanine nucleotide concentrations. Lennard L, Van Loon JA, Lilleyman JS, Weinshilboum RM. Clin Pharmacol Ther; 1987 Jan 28; 41(1):18-25. PubMed ID: 3467886 [Abstract] [Full Text] [Related]
5. Congenital thiopurine methyltransferase deficiency and 6-mercaptopurine toxicity during treatment for acute lymphoblastic leukaemia. Lennard L, Gibson BE, Nicole T, Lilleyman JS. Arch Dis Child; 1993 Nov 28; 69(5):577-9. PubMed ID: 8257179 [Abstract] [Full Text] [Related]
6. Mercaptopurine metabolism and risk of relapse in childhood lymphoblastic leukaemia. Lilleyman JS, Lennard L. Lancet; 1994 May 14; 343(8907):1188-90. PubMed ID: 7909868 [Abstract] [Full Text] [Related]
7. Mercaptopurine therapy intolerance and heterozygosity at the thiopurine S-methyltransferase gene locus. Relling MV, Hancock ML, Rivera GK, Sandlund JT, Ribeiro RC, Krynetski EY, Pui CH, Evans WE. J Natl Cancer Inst; 1999 Dec 01; 91(23):2001-8. PubMed ID: 10580024 [Abstract] [Full Text] [Related]
8. Possible implication of thiopurine S-methyltransferase in occurrence of infectious episodes during maintenance therapy for childhood lymphoblastic leukemia with mercaptopurine. Dervieux T, Médard Y, Verpillat P, Guigonis V, Duval M, Lescoeur B, Suciu S, Vilmer E, Jacqz-Aigrain E. Leukemia; 2001 Nov 01; 15(11):1706-12. PubMed ID: 11681411 [Abstract] [Full Text] [Related]
9. Thiopurine drugs in the treatment of childhood leukaemia: the influence of inherited thiopurine methyltransferase activity on drug metabolism and cytotoxicity. Lennard L, Welch JC, Lilleyman JS. Br J Clin Pharmacol; 1997 Nov 01; 44(5):455-61. PubMed ID: 9384462 [Abstract] [Full Text] [Related]
10. Differences between children and adults in thiopurine methyltransferase activity and metabolite formation during thiopurine therapy: possible role of concomitant methotrexate. Pettersson B, Almer S, Albertioni F, Söderhäll S, Peterson C. Ther Drug Monit; 2002 Jun 01; 24(3):351-8. PubMed ID: 12021625 [Abstract] [Full Text] [Related]
11. Thiopurine methyltransferase and 6-thioguanine nucleotide measurement: early experience of use in clinical practice. Gearry RB, Barclay ML, Roberts RL, Harraway J, Zhang M, Pike LS, George PM, Florkowski CM. Intern Med J; 2005 Oct 01; 35(10):580-5. PubMed ID: 16207256 [Abstract] [Full Text] [Related]
12. Thiopurine S-methyltransferase phenotype-genotype correlation in children with acute lymphoblastic leukemia. Chrzanowska M, Kuehn M, Januszkiewicz-Lewandowska D, Kurzawski M, Droździk M. Acta Pol Pharm; 2012 Oct 01; 69(3):405-10. PubMed ID: 22594254 [Abstract] [Full Text] [Related]
19. Pharmacokinetics and metabolism of thiopurines in children with acute lymphoblastic leukemia receiving 6-thioguanine versus 6-mercaptopurine. Erb N, Harms DO, Janka-Schaub G. Cancer Chemother Pharmacol; 1998 Oct 01; 42(4):266-72. PubMed ID: 9744770 [Abstract] [Full Text] [Related]
20. The pharmacokinetic effect of adalimumab on thiopurine metabolism in Crohn's disease patients. Wong DR, Pierik M, Seinen ML, van Bodegraven AA, Gilissen LP, Bus P, Bakker JA, Masclee AA, Neef C, Engels LG, Hooymans PM. J Crohns Colitis; 2014 Feb 01; 8(2):120-8. PubMed ID: 23932783 [Abstract] [Full Text] [Related] Page: [Next] [New Search]